Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alkermes Sees Payer Savings Opportunity With Aristada Approval

Oct 06 2015

Related Content

Long-Acting Atypical Antipsychotic Market Snapshot: A One-Company Market Begins To Diversify

Mar 18 2013

Alkermes Says New Aripiprazole Is Just The Start Of A Blockbuster Streak

Mar 03 2015

Related Companies

Alkermes plc

Otsuka Holdings Co., Ltd.

Johnson & Johnson

Additional Topics

United States Ireland Europe Business Strategies BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window